A phase I study of pemetrexed in combination with docetaxel in advanced solid tumor patients

被引：0
|
作者：
Cranmer, Lee D. [1 ]
Morgan, Sherif S. [1 ]
Bauland, Amy S. [1 ]
Burruel, Yrma [1 ]
Cardenas, Jean S. [1 ]
Concannon, Terry [1 ]
Schmidt, Kathy J. [1 ]
Snyder-Walker, Robin [1 ]
Garland, Linda L. [1 ]
机构：
[1] Univ Arizona, Ctr Canc, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.2567
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2567
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors
    Pronk, LC
    Schellens, JHM
    Planting, AST
    vandenBent, MJ
    Hilkens, PHE
    vanderBurg, MEL
    deBoerDennert, M
    Ma, J
    Blanc, C
    Harteveld, M
    Bruno, R
    Stoter, G
    Verweij, J
    JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) : 1071 - 1079
  • [42] Docetaxel and ifosfamide in patients with advanced solid tumors: Results of a phase I study
    Pronk, LC
    Schrijvers, D
    Schellens, JHM
    de Bruijn, EA
    Planting, AST
    Locci-Tonelli, D
    Groult, V
    Verweij, J
    van Oosterom, AT
    SEMINARS IN ONCOLOGY, 1998, 25 (01) : 23 - 28
  • [43] A phase I and pharmacokinetic study of exisulind and docetaxel in patients with advanced solid tumors
    Witta, SE
    Gustafson, DL
    Pierson, AS
    Menter, A
    Holden, SN
    Basche, M
    Persky, M
    O'Bryant, CL
    Zeng, C
    Baron, A
    Long, ME
    Gibbs, A
    Kelly, K
    Bunn, PA
    Chan, DC
    Pallansch, P
    Eckhardt, SG
    CLINICAL CANCER RESEARCH, 2004, 10 (21) : 7229 - 7237
  • [44] A phase I and pharmacokinetic study of pemetrexed plus irinotecan in patients with advanced solid malignancies
    Rowinsky, Eric K.
    Beeram, Muralidhar
    Hammond, Lisa A.
    Schwartz, Garry
    De Bono, Johann
    Forouzesh, Baharam
    Chu, Quincy
    Latz, Jane E.
    Hong, Shengyan
    John, William
    Nguyen, Binh
    CLINICAL CANCER RESEARCH, 2007, 13 (02) : 532 - 539
  • [45] A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors
    Azzoli, Christopher G.
    Krug, Lee M.
    Gomez, Jorge
    Miller, Vincent A.
    Kris, Mark G.
    Ginsberg, Michelle S.
    Henry, Roxanne
    Jones, Jessica
    Tyson, Leslie
    Dunne, Megan
    Pizzo, Barbara
    Farmer, Amy
    Venkatraman, Ennapadam
    Steffen, Robert
    Sirotnak, F. M.
    CLINICAL CANCER RESEARCH, 2007, 13 (09) : 2692 - 2698
  • [46] Phase I study of vorinostat plus docetaxel in patients with solid tumor malignancies
    Schneider, B. J.
    Bradley, D.
    Smith, D. C.
    Egorin, M.
    Kalemkerian, G.
    Dunn, R.
    Daignault, S.
    Hussain, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] Phase I trial of the sequential administration of pemetrexed (P) and docetaxel (D) in patients (pts) with advanced solid tumours.
    Lopez-Martin, A
    Cubedo, R
    Garcia-Rivas, I
    Castellano, D
    Perez-Romero, A
    Savulsky, C
    Rodriguez, R
    España, P
    Cortes-Funes, H
    Paz-Ares, L
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 161S - 161S
  • [48] Phase I study of TRC102 in combination with cisplatin and pemetrexed in patients with advanced solid tumors/Phase II study of TRC102 with pemetrexed in patients with mesothelioma refractory to pemetrexed and cisplatin or carboplatin.
    Koczywas, Marianna
    Frankel, Paul Henry
    Riess, Jonathan W.
    El-Khoueiry, Anthony B.
    Villaruz, Liza C.
    Leong, Stephen
    Ruel, Christopher
    Synold, Timothy W.
    O'Connor, Timothy
    Newman, Edward M.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Phase I study of the combination of docetaxel (D) and pemetrexed (P) in patients with advanced unresectable or metastatic non small cell lung cancer (NSCLC)
    Kotsakis, A.
    Agelaki, S.
    Vardakis, N.
    Vamvakas, L.
    Kalykaki, A.
    Kentepozidis, N.
    Kontopodis, E.
    Sfakiotaki, G.
    Mavroudis, D.
    Georgoulias, V.
    EJC SUPPLEMENTS, 2009, 7 (02): : 527 - 527
  • [50] Phase I Study of the Non -Receptor Tyrsine Kinase Inhibitor (NKI) Bosutinib in Combination with Pemetrexed in Patients with Advanced Solid Tumors
    Karim, Nagla
    Bahassi, El-Mustapha
    Gaber, Ola
    Sadraei, Nooshin Hashemi
    Morris, John
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S904 - S904
12345